With respect to antioxidant enzymes activities, the subjects with MS had significantly lower CAT (p = 0.02), SOD (p<0.01), and GPx activities (p<0.01) than the subjects in the control group. The gene discussed is SOD1; the disease is myeloid sarcoma.